LaszloEndrenyi Department of Pharmacology and Toxicology, University of Toronto, 1 King’s College Circle, Toronto, ON, M5S 1A8
Cite
Endrenyi, Laszlo. “Biosimilar Clinical Development – Scientific Considerations and New Methodologies”. Journal of Biopharmaceutical Statistics, vol. 27, no. 6, 2017, pp. 1115-7, https://doi.org/10.1080/10543406.2017.1362564.
Endrenyi, L. (2017). Biosimilar Clinical Development – Scientific Considerations and New Methodologies. Journal of Biopharmaceutical Statistics, 27(6), 1115-1117. https://doi.org/10.1080/10543406.2017.1362564
Endrenyi L. Biosimilar Clinical Development – Scientific Considerations and New Methodologies. Journal of Biopharmaceutical Statistics. 2017;27(6):1115-7.